Quest Diagnostics Incorporated: Testing Growth Keeps Me Bullish Despite Medicare HeadwindsSeeking Alpha • 09/23/26
Quest Diagnostics to Release Third Quarter Financial Results on October 22, 2026PRNewsWire • 09/22/26
Quest Diagnostics Study Finds High Tick-Borne Disease Co-ExposureZacks Investment Research • 09/22/26
Nearly 1 in 3 Patients with Suspected Lyme Disease are Co-Positive for Other Tick-Borne Pathogens, Finds Study by Quest DiagnosticsPRNewsWire • 09/21/26
Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive PicksZacks Investment Research • 09/17/26
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 09/16/26
Nine in 10 Voters Express Concern That Medicare Lab Payment Cuts Will Harm Patient Access to Diagnostic Lab Testing, Finds National Survey from Quest DiagnosticsPRNewsWire • 09/16/26
Quest Diagnostics Incorporated (DGX) Presents at 2026 Global Healthcare Conference TranscriptSeeking Alpha • 09/15/26
Quest Diagnostics Incorporated (DGX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy?Zacks Investment Research • 09/14/26
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in FocusZacks Investment Research • 09/08/26
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 08/31/26
Quest Diagnostics to Speak at the Morgan Stanley 24th Annual Global Healthcare ConferencePRNewsWire • 08/24/26
Quest Diagnostics to Offer FDA-Cleared Roche pTau217 Blood Test to Assess Alzheimer's Disease PathologyPRNewsWire • 08/24/26
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 08/21/26